سامانه مدیریت نشریات علمی دانشگاه علوم پزشکی مشهد

Mehta, Rupa, Chakravarty, Sharmistha, Nagarkar, Nitin, Gupta, Ashish, Banjare, Amit. (1401). Mammary Analogue Secretory Carcinoma of Submandibular gland. , 34(3), 191-197. doi: 10.22038/ijorl.2022.59803.3062
Rupa Mehta; Sharmistha Chakravarty; Nitin M Nagarkar; Ashish K Gupta; Amit Banjare. "Mammary Analogue Secretory Carcinoma of Submandibular gland". , 34, 3, 1401, 191-197. doi: 10.22038/ijorl.2022.59803.3062
Mehta, Rupa, Chakravarty, Sharmistha, Nagarkar, Nitin, Gupta, Ashish, Banjare, Amit. (1401). 'Mammary Analogue Secretory Carcinoma of Submandibular gland', , 34(3), pp. 191-197. doi: 10.22038/ijorl.2022.59803.3062
Mehta, Rupa, Chakravarty, Sharmistha, Nagarkar, Nitin, Gupta, Ashish, Banjare, Amit. Mammary Analogue Secretory Carcinoma of Submandibular gland. , 1401; 34(3): 191-197. doi: 10.22038/ijorl.2022.59803.3062

Mammary Analogue Secretory Carcinoma of Submandibular gland

Iranian Journal of Otorhinolaryngology
مقاله 8، دوره 34، شماره 3، مرداد و شهریور 2022، صفحه 191-197    اصل مقاله (646.94 K)
نوع مقاله: Case Report
شناسه دیجیتال (DOI): 10.22038/ijorl.2022.59803.3062
نویسندگان
Rupa Mehta1؛ Sharmistha Chakravarty* 1؛ Nitin M Nagarkar1؛ Ashish K Gupta2؛ Amit Banjare1
1Department of ENT and Head Neck Surgery, All India Institute of Medical Sciences, Raipur- 492099, Chhattisgarh, India.
2Department of Pathology, All India Institute of Medical Sciences (AIIMS), Raipur- 492099, Chhattisgarh, India.
چکیده
Introduction:
Mammary Analogue Secretory Carcinoma of salivary glands (MASC) is a low-grade carcinoma of salivary glands of the head-neck region. It bears histological resemblance to Secretory Carcinoma of the breast and Acinic Cell Carcinoma (ACC) of the parotid gland. Its clinical behaviour and aggressiveness vary amongst individuals and experience in MASC of the submandibular gland are limited.
 
Case Report:
We report a 16-year-old female with binary neck swelling in the submandibular region. The hard swelling in the submandibular region was a MASC and the soft cystic mass was a synchronous congenital lymphatic cyst in the neck. We report two unusual features, an extremely rare involvement of MASC of submandibular salivary gland and the presence of a congenital lymphatic cyst in the area adjacent to the main tumour mass. Treatment was done by surgical excision of both the neck masses in-toto and ipsilateral selective neck dissection (Level I-IV).
Conclusions:
While MASC's histological pattern has been described in previous studies, its clinical picture is rarely documented. This report aims to shed light on the clinical presentation of this under-diagnosed entity and the aggressive management protocol required during preoperative workup, intraoperative disease clearance and post-operative follow up of such patients. MASC of the submandibular salivary gland is an uncommon cause of neck swelling in the adolescent age group, but due to its occasional aggressive nature, should be borne in mind as a possible differential diagnosis of salivary gland tumours.
کلیدواژه‌ها
Lymphatic cyst؛ Mammary Analogue Secretory Carcinoma؛ Neck dissection؛ Submandibular gland
مراجع
  1. Seethala RR, Stenman G. Update from the 4th Edition of the World Health Organization Classification of Head and Neck Tumours: Tumors of the Salivary Gland. Head Neck Pathol. 2017 Mar; 11(1):55-67. doi: 10.1007/s12105-017-0795-0. Epub 2017 Feb 28. PMID: 28247227; PMCID: PMC5340736.
  2. Sethi R, Kozin E, Remenschneider A, Meier J, VanderLaan P, Faquin W, et al. Mammary analogue secretory carcinoma: Update on a new diagnosis of salivary gland malignancy, Laryngoscope. 124 (2014): 188–195.
  3. Skálová A, Vanecek T, Sima R, Laco J, Weinreb I, Perez-Ordonez B et al. Mammary analogue secretory carcinoma of salivary glands, containing the etv6- ntrk3 fusion gene: a hitherto undescribed salivary gland tumorentity.The American Journal of Surgical Pathology. 2010; 34:no.5,599–608.
  4. Tognon C, Knezevich SR, Huntsman D, Roskelley CD, Melnyk N, Mathers JA et al. Expression of the ETV6-NTRK3 gene fusion as a primary event in human secretory breast carcinoma. Cancer Cell. 2002 Nov;2(5):367-76. doi: 10.1016/ s1535- 6108(02)00180-0.PMID:12450792.
  5. Ellis GLAPL. Acinic cell adenocarcinoma. In: Ellis, GLAPL, editor. AFIP Atlas of TumorPathology: Tumors of the Salivary Glands. Washington, D.C: ARP Press; 2008. p. 204-224.
  6. Ellis GL, Corio RL. Acinic cell adenocarcinoma. A clinicopatho- logicanalysis of 294 cases. Cancer. 1983; 52: 542–549. [PubMed: 6861091]
  7. Batsakis JG, Chinn EK, Weimert TA, Work WP, Krause CJ. Acinic cell carcinoma: a clinicopathologic study of thirty-five cases. J Laryngol Otol. 1979 Apr; 93(4):325-40. PMID: 438614.
  8. Lewis JE, Olsen KD, Weiland LH. Acinic cell carcinoma. Clinicopathologic review. Cancer. 1991; 67: 172–179. [PubMed: 1985714]
  9. Hoffman HT, Karnell LH, Robinson RA, Pinkston JA, Menck HR. National Cancer Data Base report on cancer of the head and neck: acinic cell carcinoma. Head Neck. 1999 Jul;21(4):297-309. PMID: 10376748.
  10. Balogh KPL. Mouth nose, paranasal sinuses. In: Mills, SE., editor. Histology for Pathologists. Philadelphia: Lippincott, Williams, & Wilkins; 2007. p. 403-430.
  11. Griffith CC, Stelow EB, Saqi A. et al., “The cytological features of mammary analogue secretory carcinoma: a series of 6 molecularly confirmed cases,” Cancer Cytopathology, vol. 121, no. 5, pp. 234–241, 2013.
  12. Luk PP, Selinger CI, Eviston TJ, Lum T, Yu B, O’Toole SA, et al. Mammary analogue secretory carcinoma: an evaluation of its clini­copathological and genetic characteristics. Pathology. 2015; 47: 659-66.
  13. Majewska H, Skálová A, Stodulski D, Klimková A, Steiner P, Stankiewicz C et al. Mammary analogue secretory carcinoma of salivary glands: a newentity associated with ETV6 gene rearrangement, Virchows Arch. 466 (2015): 245–254.
  14. Skálová A, Vanecek T, Majewska H, Laco J, Grossmann P, Simpson RH et al. Mammary analogue secretory carcinoma of salivary glands with high-
 

grade transformation: report of 3 cases with the ETV6-NTRK3 gene fusion and analysis of TP53, β-catenin, EGFR, and CCND1 genes. Am J SurgPathol. 2014 Jan;38(1):23-33.

  1. A. Bishop, R. Yonescu, D. Batista, D.W. Eisele, W.H. Westra, Most nonparotid“acinic cell carcinomas” represent mammary analog secretory carcinomas,Am. J. Surg. Pathol. 37(2013)1053–7.
  2. Damjanov, F. Skenderi, S. Vranic, Mammary Analogue Secretory Carcinoma(MASC) of the salivary gland: a new tumor entity, Bosn. J. Basic Med. Sci. 16(2016) 237–238.
  3. F. Gonzalez, I. Akhtar, V. Manucha, Additional diagnostic features ofmammary analogue secretory carcinoma on cytology, Cytopathology 29(2018) 100–103.
  4. Suzuki, M. Yagi, A. Kanda, Y. Kobayashi, M. Konishi, C. Miyasaka, T. Tashiro,H. Iwai, Mammary analogue secretory carcinoma presenting as a cervicallymph node metastasis of unknown primary site: a case report, Case Rep.Oncol. 10 (2017) 192–198.
  5. Albus, J. Batanian, B.M. Wenig, C.I. Vidal, A unique case of a cutaneous lesionresembling mammary analog secretory carcinoma: a case report and reviewof the literature, Am. J. Dermatopathol. 37 (2015) e41–44.
  6. Drilon A, Li G, Dogan S, Gounder M, Shen R, Arcila M, et al. What hides behind the MASC: clinical response and acquired resistance to entrectinib after ETV6-NTRK3 identifica­tion in a mammary analogue secretory carcinoma (MASC). Ann Oncol. 2016 Feb 15. pii: mdw042. [Epub ahead of print] http://dx.doi.org/10.1093/annonc/ mdw0 42
آمار
تعداد مشاهده مقاله: 438
تعداد دریافت فایل اصل مقاله: 236